Scientific Paper

The highly-selective 5-HT1A agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits…

April 27, 2023

The highly-selective 5-HT1A agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits…

Back to Resources

At Atuka, we combine our capabilities with yours to harness the power of partnership and advance your therapeutic program.

Talk to a Neuroscience Expert